Cargando…

The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021

PURPOSE: To analyze the differences in clinical distribution and antimicrobial resistance of pathogens among northern Anhui, central Anhui, and southern Anhui in 2021, and to provide a basis for the rational use of drugs for clinicians in different regions. METHODS: Nonrepetitive pathogens isolated...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanyan, Wang, Wei, Guo, Mingjuan, Xu, Zhicheng, Yang, Yi, Yu, Liang, Li, Yasheng, Hu, Lifen, Ye, Ying, Li, Jiabin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790164/
https://www.ncbi.nlm.nih.gov/pubmed/36575674
http://dx.doi.org/10.2147/IDR.S393760
_version_ 1784859113758392320
author Liu, Yanyan
Wang, Wei
Guo, Mingjuan
Xu, Zhicheng
Yang, Yi
Yu, Liang
Li, Yasheng
Hu, Lifen
Ye, Ying
Li, Jiabin
author_facet Liu, Yanyan
Wang, Wei
Guo, Mingjuan
Xu, Zhicheng
Yang, Yi
Yu, Liang
Li, Yasheng
Hu, Lifen
Ye, Ying
Li, Jiabin
author_sort Liu, Yanyan
collection PubMed
description PURPOSE: To analyze the differences in clinical distribution and antimicrobial resistance of pathogens among northern Anhui, central Anhui, and southern Anhui in 2021, and to provide a basis for the rational use of drugs for clinicians in different regions. METHODS: Nonrepetitive pathogens isolated from clinical samples of inpatients and outpatients from 59 member units with qualified data in 2021 were obtained from the Anhui Province Antimicrobial Resistance Surveillance System, which was divided into northern Anhui, central Anhui, and southern Anhui by region. Identification and antimicrobial susceptibility analyses were carried out using the Vitek 2 Compact and standard disc diffusion method. The results were determined according to the American Clinical Laboratory Standards Institute in 2021 with data analyzed using WHONET 5.6 and SPSS 17.0. RESULTS: A total of 133,268 pathogenic bacteria were isolated from clinical samples. Staphylococcus aureus (S. aureus) was the most common gram-positive bacterium and Escherichia coli (E. coli) was the most common gram-negative bacterium. Sputum was the main source of clinical specimens. The detection rates of methicillin-resistant S.aureus, methicillin-resistant coagulase-negative Staphylococcus, carbapenem-resistant E. coli, carbapenem-resistant Klebsiella pneumoniae (K. pneumoniae), carbapenem-resistant Acinetobacter baumannii, third-generation cephalosporin-resistant E. coli, and third-generation cephalosporin-resistant K. pneumoniae were higher in northern Anhui than in southern Anhui (P<0.0001). E. coli, K. pneumoniae, and Pseudomonas aeruginosa were sensitive to amikacin. Strains resistant to vancomycin, linezolid, and teicoplanin were not isolated until 2021. CONCLUSION: There were significant differences in bacterial resistance in different regions of Anhui Province. Antibiotic resistance in northern Anhui was the most serious in 2021. Antimicrobial agents must be used according to the resistance of the bacteria in the local region.
format Online
Article
Text
id pubmed-9790164
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97901642022-12-26 The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021 Liu, Yanyan Wang, Wei Guo, Mingjuan Xu, Zhicheng Yang, Yi Yu, Liang Li, Yasheng Hu, Lifen Ye, Ying Li, Jiabin Infect Drug Resist Original Research PURPOSE: To analyze the differences in clinical distribution and antimicrobial resistance of pathogens among northern Anhui, central Anhui, and southern Anhui in 2021, and to provide a basis for the rational use of drugs for clinicians in different regions. METHODS: Nonrepetitive pathogens isolated from clinical samples of inpatients and outpatients from 59 member units with qualified data in 2021 were obtained from the Anhui Province Antimicrobial Resistance Surveillance System, which was divided into northern Anhui, central Anhui, and southern Anhui by region. Identification and antimicrobial susceptibility analyses were carried out using the Vitek 2 Compact and standard disc diffusion method. The results were determined according to the American Clinical Laboratory Standards Institute in 2021 with data analyzed using WHONET 5.6 and SPSS 17.0. RESULTS: A total of 133,268 pathogenic bacteria were isolated from clinical samples. Staphylococcus aureus (S. aureus) was the most common gram-positive bacterium and Escherichia coli (E. coli) was the most common gram-negative bacterium. Sputum was the main source of clinical specimens. The detection rates of methicillin-resistant S.aureus, methicillin-resistant coagulase-negative Staphylococcus, carbapenem-resistant E. coli, carbapenem-resistant Klebsiella pneumoniae (K. pneumoniae), carbapenem-resistant Acinetobacter baumannii, third-generation cephalosporin-resistant E. coli, and third-generation cephalosporin-resistant K. pneumoniae were higher in northern Anhui than in southern Anhui (P<0.0001). E. coli, K. pneumoniae, and Pseudomonas aeruginosa were sensitive to amikacin. Strains resistant to vancomycin, linezolid, and teicoplanin were not isolated until 2021. CONCLUSION: There were significant differences in bacterial resistance in different regions of Anhui Province. Antibiotic resistance in northern Anhui was the most serious in 2021. Antimicrobial agents must be used according to the resistance of the bacteria in the local region. Dove 2022-12-21 /pmc/articles/PMC9790164/ /pubmed/36575674 http://dx.doi.org/10.2147/IDR.S393760 Text en © 2022 Liu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Liu, Yanyan
Wang, Wei
Guo, Mingjuan
Xu, Zhicheng
Yang, Yi
Yu, Liang
Li, Yasheng
Hu, Lifen
Ye, Ying
Li, Jiabin
The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021
title The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021
title_full The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021
title_fullStr The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021
title_full_unstemmed The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021
title_short The Analysis of Drug-Resistant Bacteria from Different Regions of Anhui in 2021
title_sort analysis of drug-resistant bacteria from different regions of anhui in 2021
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790164/
https://www.ncbi.nlm.nih.gov/pubmed/36575674
http://dx.doi.org/10.2147/IDR.S393760
work_keys_str_mv AT liuyanyan theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT wangwei theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT guomingjuan theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT xuzhicheng theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT yangyi theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT yuliang theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT liyasheng theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT hulifen theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT yeying theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT lijiabin theanalysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT liuyanyan analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT wangwei analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT guomingjuan analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT xuzhicheng analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT yangyi analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT yuliang analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT liyasheng analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT hulifen analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT yeying analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021
AT lijiabin analysisofdrugresistantbacteriafromdifferentregionsofanhuiin2021